MDG1:FRA
MediGene AG
0,017 €
arrow_upward
+3,61%(+0,00060) 1D
30. lip, 22:00:00 GMT+2 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
Vijesti
Iz web-izvora i od partnera za vijesti
SEEbiz.eu
·
prije 3 sata
Wall Street: Micron gubitnik dana, samo Dow Jones u plusu
Poslovni dnevnik
·
prije 16 sati
S&P 500 i Nasdaq dosegnuli rekorde, sada dolazi ključni test: Očekuje se rast zarada veći od 30 posto
New York Post
·
prije 11 minuta
NYSE's opening bell honors Italian Americans who beat stereotypes to reach pinnacle of finance
Profil
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia